Concepedia

Catherine J. Larsson

CJ

Statistics

Publications

15

Citations

1.2K

H-Index

15

Active since

2005

Affiliations

University of Vermont(Current)

Johns Hopkins University

National Institute of Allergy and Infectious Diseases

Johns Hopkins Medicine

Uniformed Services University of the Health Sciences

Catherine J. Larsson is an author at University of Vermont specializing in immunology, medicine, and pathogenesis.

Top concepts

Publications per year

2005–2017

15

Publications

15

The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model

Beth D. Kirkpatrick, Stephen S. Whitehead, Kristen K. Pierce et al. · Science Translational Medicine · 2016 · 252 citations

Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults

Beth D. Kirkpatrick, Anna P. Durbin, Kristen K. Pierce et al. · The Journal of Infectious Diseases · 2015 · 195 citations · Full text

A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial

Anna P. Durbin, Beth D. Kirkpatrick, Kristen K. Pierce et al. · The Journal of Infectious Diseases · 2013 · 164 citations · Full text

Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers

Beth D. Kirkpatrick, Robin McKenzie, John P. O’Neill et al. · Vaccine · 2005 · 99 citations

, , +10

In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination

Stephen S. Whitehead, Anna P. Durbin, Kristen K. Pierce et al. · PLoS neglected tropical diseases · 2017 · 99 citations · Full text

1–5 of 15